Association of adult mastocytosis with M541L in the transmembrane domain of KIT

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 9, 2010, Pages 1118-1119

  Rocha, J ^a   Luz Duarte, M ^a   Marques, H ^a   Torres, F ^b   Tavares, P ^b   Silva, A ^a   Brito, C ^a  

^a HOSPITAL DE BRAGA   (Portugal)

^b Centro de Gené Tica Clý nica   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD33 ANTIGEN; CD45 ANTIGEN; CD59 ANTIGEN; CD63 ANTIGEN; CD69 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; DNA; INTERLEUKIN 2 RECEPTOR ALPHA; KIT PROTEIN; LEUCINE; METHIONINE; ONCOPROTEIN; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; CASE REPORT; CODON; DARIER DISEASE; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; KARYOTYPE 46,XX; LETTER; MOUTH MUCOSA; PAPULE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTO ONCOGENE; SKIN BIOPSY; SKIN INFILTRATE; URTICARIA PIGMENTOSA;

ADULT; FEMALE; HUMANS; MASTOCYTOSIS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 77955243005     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03599.x     Document Type: Letter

References (9)

1. Orfao A, Garcia-Montero AC, Sanchez L, Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007 138 : 12 30.
2. Garcia-Montero AC, Jara-Acevedo M, Teodosio C et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006 108 : 2366 2372.
3. Furitsu T, Tsujimura T, Tono T et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993 92 : 1736 1744.
4. Krüger S, Emig M, Lohse P et al. The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians. Leukemia 2006 20 : 354 355.
5. Murakami T, Fukai K, Oiso N et al. New KIT mutations in patients with piebaldism. J Dermatol Sci 2004 35 : 29 33.
6. Foster R, Byrnes E, Meldrum C et al. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT. Br J Dermatol 2008 159 : 1160 1169.
7. Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001 25 : 603 625.
8. Pardanani A, Kimlinger T, Reeder T et al. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 2004 28 : 777 783.
9. Hollmann TJ, Brenn T, Hornick JL. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis. Am J Surg Pathol 2008 32 : 139 145.